Antilipemic AgentsLopid (gemfibrozil) Tablets
Manufacturer: Pfizer, Inc.
Drug Approval Classification: Supplemental NDA (approval date: 1/15/03)
Adverse Effects: Lopid (gemfibrozil) labeling was revised to include the following statement:
Cases of cholelithiasis have been reported with gemfibrozil therapy.
Lopid (gemfibrozil) Tablets Letter
Medscape Pharmacists. 2003;4(1) © 2003 Medscape
Cite this: February 2003 - Medscape - Feb 20, 2003.